Software - Infrastructure
Compare Stocks
5 / 10Stock Comparison
HPAIW vs AIRS vs SKIN vs AISP vs AMZN
Revenue, margins, valuation, and 5-year total return — side by side.
Medical - Care Facilities
Household & Personal Products
Software - Infrastructure
Specialty Retail
HPAIW vs AIRS vs SKIN vs AISP vs AMZN — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Software - Infrastructure | Medical - Care Facilities | Household & Personal Products | Software - Infrastructure | Specialty Retail |
| Market Cap | $9.00 | $272M | $75M | $88M | $2.93T |
| Revenue (TTM) | $30M | $152M | $296M | $15M | $742.78B |
| Net Income (TTM) | $7M | $-11M | $-6M | $29.32B | $90.80B |
| Gross Margin | 62.8% | 46.9% | 64.9% | 50.2% | 50.6% |
| Operating Margin | 31.1% | -8.1% | -3.6% | -47.1% | 11.5% |
| Forward P/E | — | — | — | 3.4x | 31.4x |
| Total Debt | $5M | $84M | $379M | $864M | $152.99B |
| Cash & Equiv. | $3M | $8M | $233M | $11.75B | $86.81B |
HPAIW vs AIRS vs SKIN vs AISP vs AMZN — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Aug 24 | May 26 | Return |
|---|---|---|---|
| Helport AI Limited (HPAIW) | 100 | 40.0 | -60.0% |
| AirSculpt Technolog… (AIRS) | 100 | 67.5 | -32.5% |
| The Beauty Health C… (SKIN) | 100 | 49.7 | -50.3% |
| Airship AI Holdings… (AISP) | 100 | 72.7 | -27.3% |
| Amazon.com, Inc. (AMZN) | 100 | 116.7 | +16.7% |
Price return only. Dividends and distributions are not included.
Quick Verdict: HPAIW vs AIRS vs SKIN vs AISP vs AMZN
Each card shows where this stock fits in a portfolio — not just who wins on paper.
HPAIW ranks third and is worth considering specifically for growth.
- 132.4% revenue growth vs AISP's -33.5%
AIRS lags the leaders in this set but could rank higher in a more targeted comparison.
Among these 5 stocks, SKIN doesn't own a clear edge in any measured category.
AISP carries the broadest edge in this set and is the clearest fit for defensive.
- Beta 2.61, current ratio 2.94x
- Lower P/E (3.4x vs 31.4x)
- 1.9K% margin vs AIRS's -7.4%
- 150.6% ROA vs AIRS's -5.9%
AMZN is the #2 pick in this set and the best alternative if income & stability and growth exposure is your priority.
- beta 1.50
- Rev growth 12.4%, EPS growth 29.7%, 3Y rev CAGR 11.7%
- 7.0% 10Y total return vs AIRS's -73.1%
- Lower volatility, beta 1.50, Low D/E 37.2%, current ratio 1.05x
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 132.4% revenue growth vs AISP's -33.5% | |
| Value | Lower P/E (3.4x vs 31.4x) | |
| Quality / Margins | 1.9K% margin vs AIRS's -7.4% | |
| Stability / Safety | Beta 1.50 vs AIRS's 2.97, lower leverage | |
| Dividends | Tie | None of these 5 stocks pay a meaningful dividend |
| Momentum (1Y) | +42.0% vs HPAIW's -76.0% | |
| Efficiency (ROA) | 150.6% ROA vs AIRS's -5.9% |
HPAIW vs AIRS vs SKIN vs AISP vs AMZN — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
HPAIW vs AIRS vs SKIN vs AISP vs AMZN — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
HPAIW leads in 2 of 6 categories
AISP leads 1 • AMZN leads 1 • AIRS leads 0 • SKIN leads 0 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
AISP leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
AMZN is the larger business by revenue, generating $742.8B annually — 48479.9x AISP's $15M. AISP is the more profitable business, keeping 1913.8% of every revenue dollar as net income compared to AIRS's -7.4%. On growth, AISP holds the edge at +102.5% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $30M | $152M | $296M | $15M | $742.8B |
| EBITDAEarnings before interest/tax | — | $268,999 | $9M | -$7M | $155.9B |
| Net IncomeAfter-tax profit | — | -$11M | -$6M | $29.3B | $90.8B |
| Free Cash FlowCash after capex | — | $7M | $29M | -$1.8B | -$2.5B |
| Gross MarginGross profit ÷ Revenue | +62.8% | +46.9% | +64.9% | +50.2% | +50.6% |
| Operating MarginEBIT ÷ Revenue | +31.1% | -8.1% | -3.6% | -47.1% | +11.5% |
| Net MarginNet income ÷ Revenue | +24.9% | -7.4% | -2.0% | +1913.8% | +12.2% |
| FCF MarginFCF ÷ Revenue | -8.0% | +4.6% | +9.7% | -119.3% | -0.3% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | +0.0% | -6.7% | +102.5% | +16.6% |
| EPS Growth (YoY)Latest quarter vs prior year | — | +38.3% | +38.0% | +155.6% | +74.8% |
Valuation Metrics
HPAIW leads this category, winning 3 of 5 comparable metrics.
Valuation Metrics
At 3.4x trailing earnings, AISP trades at a 91% valuation discount to AMZN's 38.0x P/E. On an enterprise value basis, HPAIW's 0.2x EV/EBITDA is more attractive than SKIN's 48.6x.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $9 | $272M | $75M | $88M | $2.93T |
| Enterprise ValueMkt cap + debt − cash | $2M | $347M | $221M | -$10.8B | $3.00T |
| Trailing P/EPrice ÷ TTM EPS | — | -20.32x | -3.63x | 3.36x | 38.03x |
| Forward P/EPrice ÷ next-FY EPS est. | — | — | — | — | 31.41x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — | 1.36x |
| EV / EBITDAEnterprise value multiple | 0.20x | 43.71x | 48.65x | — | 20.58x |
| Price / SalesMarket cap ÷ Revenue | 0.00x | 1.79x | 0.25x | 5.72x | 4.09x |
| Price / BookPrice ÷ Book value/share | 0.00x | 2.66x | 1.29x | — | 7.18x |
| Price / FCFMarket cap ÷ FCF | — | 393.51x | 2.02x | — | 381.09x |
Profitability & Efficiency
HPAIW leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
HPAIW delivers a 78.7% return on equity — every $100 of shareholder capital generates $79 in annual profit, vs $-12 for AIRS. AMZN carries lower financial leverage with a 0.37x debt-to-equity ratio, signaling a more conservative balance sheet compared to SKIN's 6.20x. On the Piotroski fundamental quality scale (0–9), SKIN scores 7/9 vs AIRS's 3/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +78.7% | -12.4% | -9.4% | — | +23.3% |
| ROA (TTM)Return on assets | +32.1% | -5.9% | -1.2% | +150.6% | +11.5% |
| ROICReturn on invested capital | +65.5% | -2.1% | -6.8% | — | +14.7% |
| ROCEReturn on capital employed | +98.2% | -2.8% | -4.5% | -0.1% | +15.3% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 3 | 7 | 5 | 6 |
| Debt / EquityFinancial leverage | 0.37x | 0.95x | 6.20x | — | 0.37x |
| Net DebtTotal debt minus cash | $2M | $75M | $146M | -$10.9B | $66.2B |
| Cash & Equiv.Liquid assets | $3M | $8M | $233M | $11.8B | $86.8B |
| Total DebtShort + long-term debt | $5M | $84M | $379M | $864M | $153.0B |
| Interest CoverageEBIT ÷ Interest expense | 40.57x | -1.16x | 0.79x | -0.48x | 39.96x |
Total Returns (Dividends Reinvested)
AMZN leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in AMZN five years ago would be worth $17,094 today (with dividends reinvested), compared to $471 for SKIN. Over the past 12 months, AMZN leads with a +42.0% total return vs HPAIW's -76.0%. The 3-year compound annual growth rate (CAGR) favors AMZN at 37.1% vs SKIN's -62.5% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -62.3% | +108.6% | -58.6% | -18.0% | +20.4% |
| 1-Year ReturnPast 12 months | -76.0% | +36.4% | -53.2% | -34.4% | +42.0% |
| 3-Year ReturnCumulative with dividends | -77.8% | -26.3% | -94.7% | -74.7% | +157.7% |
| 5-Year ReturnCumulative with dividends | -77.8% | -73.1% | -95.3% | -74.0% | +70.9% |
| 10-Year ReturnCumulative with dividends | -77.8% | -73.1% | -94.6% | -74.0% | +702.2% |
| CAGR (3Y)Annualised 3-year return | -39.4% | -9.7% | -62.5% | -36.8% | +37.1% |
Risk & Volatility
Evenly matched — HPAIW and AMZN each lead in 1 of 2 comparable metrics.
Risk & Volatility
HPAIW is the less volatile stock with a -0.11 beta — it tends to amplify market swings less than AIRS's 2.97 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. AMZN currently trades 97.9% from its 52-week high vs HPAIW's 21.4% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | -0.11x | 2.97x | 1.71x | 2.61x | 1.50x |
| 52-Week HighHighest price in past year | $0.28 | $12.00 | $2.69 | $7.20 | $278.56 |
| 52-Week LowLowest price in past year | $0.06 | $1.51 | $0.57 | $2.04 | $188.82 |
| % of 52W HighCurrent price vs 52-week peak | +21.4% | +32.2% | +21.6% | +35.4% | +97.9% |
| RSI (14)Momentum oscillator 0–100 | 37.5 | 66.1 | 49.5 | 54.3 | 74.2 |
| Avg Volume (50D)Average daily shares traded | 5K | 3.1M | 844K | 437K | 45.2M |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
Analyst consensus: AIRS as "Hold", SKIN as "Hold", AMZN as "Buy". Consensus price targets imply 124.1% upside for SKIN (target: $1) vs 12.5% for AMZN (target: $307).
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Hold | Hold | — | Buy |
| Price TargetConsensus 12-month target | — | $6.00 | $1.30 | — | $306.77 |
| # AnalystsCovering analysts | — | 5 | 13 | — | 94 |
| Dividend YieldAnnual dividend ÷ price | — | — | — | — | — |
| Dividend StreakConsecutive years of raises | — | 0 | — | — | — |
| Dividend / ShareAnnual DPS | — | — | — | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
HPAIW leads in 2 of 6 categories (Valuation Metrics, Profitability & Efficiency). AISP leads in 1 (Income & Cash Flow). 1 tied.
HPAIW vs AIRS vs SKIN vs AISP vs AMZN: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is HPAIW or AIRS or SKIN or AISP or AMZN a better buy right now?
For growth investors, Helport AI Limited (HPAIW) is the stronger pick with 132.
4% revenue growth year-over-year, versus -33. 5% for Airship AI Holdings, Inc. (AISP). Airship AI Holdings, Inc. (AISP) offers the better valuation at 3. 4x trailing P/E, making it the more compelling value choice. Analysts rate Amazon. com, Inc. (AMZN) a "Buy" — based on 94 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — HPAIW or AIRS or SKIN or AISP or AMZN?
On trailing P/E, Airship AI Holdings, Inc.
(AISP) is the cheapest at 3. 4x versus Amazon. com, Inc. at 38. 0x.
03Which is the better long-term investment — HPAIW or AIRS or SKIN or AISP or AMZN?
Over the past 5 years, Amazon.
com, Inc. (AMZN) delivered a total return of +70. 9%, compared to -95. 3% for The Beauty Health Company (SKIN). Over 10 years, the gap is even starker: AMZN returned +702. 2% versus SKIN's -94. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — HPAIW or AIRS or SKIN or AISP or AMZN?
By beta (market sensitivity over 5 years), Helport AI Limited (HPAIW) is the lower-risk stock at -0.
11β versus AirSculpt Technologies, Inc. 's 2. 97β — meaning AIRS is approximately -2755% more volatile than HPAIW relative to the S&P 500. On balance sheet safety, Amazon. com, Inc. (AMZN) carries a lower debt/equity ratio of 37% versus 6% for The Beauty Health Company — giving it more financial flexibility in a downturn.
05Which is growing faster — HPAIW or AIRS or SKIN or AISP or AMZN?
By revenue growth (latest reported year), Helport AI Limited (HPAIW) is pulling ahead at 132.
4% versus -33. 5% for Airship AI Holdings, Inc. (AISP). On earnings-per-share growth, the picture is similar: Airship AI Holdings, Inc. grew EPS 140. 0% year-over-year, compared to -35. 7% for AirSculpt Technologies, Inc.. Over a 3-year CAGR, AMZN leads at 11. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — HPAIW or AIRS or SKIN or AISP or AMZN?
Airship AI Holdings, Inc.
(AISP) is the more profitable company, earning 1914% net margin versus -7. 7% for AirSculpt Technologies, Inc. — meaning it keeps 1914% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: HPAIW leads at 31. 1% versus -47. 1% for AISP. At the gross margin level — before operating expenses — SKIN leads at 65. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is HPAIW or AIRS or SKIN or AISP or AMZN more undervalued right now?
Analyst consensus price targets imply the most upside for SKIN: 124.
1% to $1. 30.
08Which pays a better dividend — HPAIW or AIRS or SKIN or AISP or AMZN?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
09Is HPAIW or AIRS or SKIN or AISP or AMZN better for a retirement portfolio?
For long-horizon retirement investors, Helport AI Limited (HPAIW) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0.
11)). Airship AI Holdings, Inc. (AISP) carries a higher beta of 2. 61 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (HPAIW: -77. 8%, AISP: -74. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between HPAIW and AIRS and SKIN and AISP and AMZN?
These companies operate in different sectors (HPAIW (Technology) and AIRS (Healthcare) and SKIN (Consumer Defensive) and AISP (Technology) and AMZN (Consumer Cyclical)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: HPAIW is a small-cap high-growth stock; AIRS is a small-cap quality compounder stock; SKIN is a small-cap quality compounder stock; AISP is a small-cap deep-value stock; AMZN is a mega-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.